Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 13/20 | 0.54 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.54 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.49 |
| ▸ | CDK2 | P24941 | 2/20 | 0.49 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.46 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31151549 | 0.90 | NPY1R (0.64) | NPY1RNPY2RNPY4RNPBWR1 | |
| SCHEMBL31151562 | 0.90 | NPY1R (0.64) | NPY1RNPY2RNPY4RNPBWR1 | |
| SCHEMBL30361862 | 0.90 | NPY1R (0.65) | NPY1RNPY2RNPY4RNPBWR1 | |
| SCHEMBL29349719 | 0.87 | FURIN (0.60) | FURINNPY1RNPY2RNPY4RSIRT2 | |
| SCHEMBL29384677 | 0.87 | FURIN (0.63) | FURINPCSK6CCNA2CDK2CCNA1 | |
| SCHEMBL29884849 | 0.87 | FURIN (0.45) | FURINPCSK6CCNA2CDK2CCNA1 | |
| SCHEMBL30361983 | 0.87 | NPY1R (0.67) | NPY1RNPY2RNPY4RNPBWR1 | |
| SCHEMBL30361827 | 0.87 | NPY4R (0.67) | NPY1RNPY2RNPY4R | |
| SCHEMBL31151720 | 0.85 | NPY4R (0.65) | NPY1RNPY2RNPY4RNPBWR1 | |
| SCHEMBL30909418 | 0.84 | BACE1 (0.49) | FURINPCSK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713002-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | Forssmann, Wolf-Georg (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4501348-A1 | PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501347-A1 | PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024235986-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | PHARIS BIOTEC GMBH (DE) | 2024-11-21 | — | — | WO | disclosed |